TRAVERE THERAPEUTICS, INC. Operating Lease, Weighted Average Discount Rate, Percent
TRAVERE THERAPEUTICS, INC. (TVTX) had Operating Lease, Weighted Average Discount Rate, Percent of 6.48% as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-08-04
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 6.48%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 6.48%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 6.48%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 6.47%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 6.48% 10-Q · filed 2026-08-04 |
| 2026-03-31 | 6.48% 10-Q · filed 2026-05-04 |
| 2025-12-31 | 6.48% 10-Q · filed 2026-08-04 |
| 2025-09-30 | 6.47% 10-Q · filed 2025-10-30 |
| 2025-06-30 | 6.47% 10-Q · filed 2025-08-06 |
| 2025-03-31 | 6.47% 10-Q · filed 2025-05-01 |
| 2024-12-31 | 6.48% 10-K · filed 2026-02-19 |
| 2024-09-30 | 6.48% 10-Q · filed 2024-10-31 |
| 2024-06-30 | 6.48% 10-Q · filed 2024-08-01 |
| 2024-03-31 | 6.48% 10-Q · filed 2024-05-06 |
| 2023-12-31 | 6.48% 10-K · filed 2025-02-21 |
| 2023-09-30 | 6.48% 10-Q · filed 2023-11-07 |
| 2023-06-30 | 6.48% 10-Q · filed 2023-08-03 |
| 2023-03-31 | 6.48% 10-Q · filed 2023-05-04 |
| 2022-12-31 | 6.48% 10-K · filed 2024-02-20 |
| 2021-12-31 | 6.47% 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |